votrient tablet
novartis pharmaceuticals canada inc - pazopanib (pazopanib hydrochloride) - tablet - 200mg - pazopanib (pazopanib hydrochloride) 200mg - antineoplastic agents
votrient tablet
novartis pharmaceuticals canada inc - pazopanib (pazopanib hydrochloride) - tablet - 400mg - pazopanib (pazopanib hydrochloride) 400mg - antineoplastic agents
votrient tablets film-coated
glaxo wellcome s.a. - pazopanib - tablets film-coated - 400mg
pazopanib lotus 200 mg film-coated tablets
lotus support services s.r.l. 47 theodor pallady blvd. 2nd office, entrance b, 1st floor 3rd district bucharest, romania - pazopanib - film-coated tablet - pazopanib 200 mg - antineoplastic agents
votrient tablets film-coated
glaxo wellcome s.a. - pazopanib - tablets film-coated - 400mg
votrient tablets film-coated
glaxo wellcome s.a. - pazopanib - tablets film-coated - 400mg
sandoz pazopanib tablet
sandoz canada incorporated - pazopanib (pazopanib hydrochloride) - tablet - 200mg - pazopanib (pazopanib hydrochloride) 200mg - antineoplastic agents
pazopanib pharos 200mg film-coated tablets
pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - pazopanib - film-coated tablet - pazopanib 200 mg - antineoplastic agents
pazopanib pharos 400mg film-coated tablets
pharos – pharmaceutical oriented services limited lesvou str. (end), thesi loggos, industrial zone, 144 52 metamorfossi attikis,, greece - pazopanib - film-coated tablet - pazopanib 400 mg - antineoplastic agents
pazopanib eg 200 mg film-coat. tabl.
eg sa-nv - pazopanib hydrochloride 216,7 mg - eq. pazopanib 200 mg - film-coated tablet - 200 mg - pazopanib hydrochloride 216.7 mg - pazopanib